These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 25562927

  • 1. [Tetrabenazine (tetrabenazine Orphan) orally].
    J Pharm Belg; 2014 Dec; (4):49-50. PubMed ID: 25562927
    [No Abstract] [Full Text] [Related]

  • 2. Tetrabenazine, depression and suicide: good news.
    Margolis RL.
    J Huntingtons Dis; 2014 Dec; 3(2):137-8. PubMed ID: 25062856
    [No Abstract] [Full Text] [Related]

  • 3. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C, Jankovic J.
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [Abstract] [Full Text] [Related]

  • 4. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ, Ondo WG, Dashtipour K, Swope DM.
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG, Breden EL.
    Ann Pharmacother; 2011 Apr; 45(4):525-31. PubMed ID: 21487088
    [Abstract] [Full Text] [Related]

  • 7. Tetrabenazine.
    Hayden MR, Leavitt BR, Yasothan U, Kirkpatrick P.
    Nat Rev Drug Discov; 2009 Jan; 8(1):17-8. PubMed ID: 19116624
    [No Abstract] [Full Text] [Related]

  • 8. Deutetrabenazine for Treatment of Chorea in Huntington Disease.
    Geschwind MD, Paras N.
    JAMA; 2016 Jul 05; 316(1):33-5. PubMed ID: 27380339
    [No Abstract] [Full Text] [Related]

  • 9. Tetrabenazine and suicidal ideation.
    Shahani L.
    J Neuropsychiatry Clin Neurosci; 2013 Jul 05; 25(1):E30. PubMed ID: 23487220
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The long-term effect of tetrabenazine in the management of Huntington disease.
    Fasano A, Cadeddu F, Guidubaldi A, Piano C, Soleti F, Zinzi P, Bentivoglio AR.
    Clin Neuropharmacol; 2008 Jul 05; 31(6):313-8. PubMed ID: 19050408
    [Abstract] [Full Text] [Related]

  • 12. Deutetrabenazine for the treatment of Huntington's chorea.
    Bashir H, Jankovic J.
    Expert Rev Neurother; 2018 Aug 05; 18(8):625-631. PubMed ID: 29996061
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacological properties and clinical efficacy of tetrabenazine (Choreazine(®)Tablets 12.5 mg), a therapeutic agent for non-rhythmic involuntary movement].
    Machida K, Kawakami D, Miki M.
    Nihon Yakurigaku Zasshi; 2014 Mar 05; 143(3):144-51. PubMed ID: 24614638
    [No Abstract] [Full Text] [Related]

  • 14. Deutetrabenazine (Austedo) for Huntington's chorea and tardive dyskinesia.
    Med Lett Drugs Ther; 2018 Apr 23; 60(1545):65-68. PubMed ID: 29667946
    [No Abstract] [Full Text] [Related]

  • 15. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
    Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J.
    Clin Neuropharmacol; 2008 Apr 23; 31(3):127-33. PubMed ID: 18520979
    [Abstract] [Full Text] [Related]

  • 16. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR.
    Am J Geriatr Pharmacother; 2010 Aug 23; 8(4):331-73. PubMed ID: 20869622
    [Abstract] [Full Text] [Related]

  • 17. Letter: Treatment of Huntington's chorea with tetrabenazine.
    Snaith RP, Warren HD.
    Lancet; 1974 Mar 09; 1(7854):413-4. PubMed ID: 4131061
    [No Abstract] [Full Text] [Related]

  • 18. An experimental model for Huntington's chorea?
    Zeef DH, Jahanshahi A, Vlamings R, Casaca-Carreira J, Santegoeds RG, Janssen ML, Oosterloo M, Temel Y.
    Behav Brain Res; 2014 Apr 01; 262():31-4. PubMed ID: 24412685
    [Abstract] [Full Text] [Related]

  • 19. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.
    Setter SM, Neumiller JJ, Dobbins EK, Wood L, Clark J, DuVall CA, Santiago A.
    Consult Pharm; 2009 Jul 01; 24(7):524-37. PubMed ID: 19689181
    [Abstract] [Full Text] [Related]

  • 20. [Therapeutic use of tetrabenazine].
    López Del Val LJ, López-García E, Martínez-Martínez L, Santos-Lasaosa S.
    Rev Neurol; 2009 Jul 01; 48(10):523-33. PubMed ID: 19434587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.